(Proprietary Platform)

GENO-VERSE

>

Pipelines

Discovery

Pre-Clinical

Clinical

Partner

Project 201
(Hematology)

Phase II

Hanmi

Estimated study completion:
Q4 2023

Project 101
(Inflammatory)

Project 301
(Hematology)

Project 401
(Inflammatory)

Project 501
(Oncology)

Project 601
(Oncology)